In an attempt to find new ways to prevent cases of MRSA, researchers have been working to develop a new vaccine. Several pharmaceutical companies have attempted to create vaccines for MRSA in the past, but such endeavors have not been successful. The main reason for this is that it is not known what makes individuals immune to the disease. Current research into a MRSA vaccine is in the very early stages, and even if a successful vaccine was developed, it would take years to receive approval.
We often blog about the importance of preventing surgical site infections. An effective vaccine to combat MRSA would be a major milestone in the fight against antibiotic resistance. This is because powerful antibiotics are used to treat active MRSA infections, and each time such therapies are used, the more likely it becomes for the bacteria to develop resistance. Thus, the most optimal treatment would be to prevent MRSA before it occurs. If a successful vaccine was to be developed, it would likely be given prior to surgical procedures, and in those with compromised immune systems. But, why wait years for a MRSA vaccine to be developed when there are simple solutions available right now? Read more »